A thematic index covering antimicrobial resistance, from laboratory diagnostics and data quality control to AMR surveillance and antimicrobial stewardship.
Key results of the 2025 analytical report by the Methodological Verification Center on antimicrobial resistance: pathogen structure among hospitalized patients, resistance levels, carbapenemases, and practical conclusions regarding antimicrobial agents.
A review of the 2025 CMAC publication: the experience of the Yamalo-Nenets Autonomous Okrug in implementing a regional system for automated validation of microbiology reports, continuous AMR surveillance, and real-time analytics.
Review of a Poliklinika journal article (2024): how the Botkin Hospital centralized bacteriology lab built an IT-enabled production flow (LIS + services), why export-based surveillance does not scale, and how the next-generation system – ABioGram – adds automated report validation and real-time AMR surveillance.
Pilot results in the largest laboratory in Moscow (07 Nov–25 Nov 2025): API integration with the laboratory information system, automated interpretation of antimicrobial susceptibility results, 89,117 decision-support messages, and real-time AMR analytics.
Review of a CMAC (2025) publication: implementation of an integrated digital loop (LIS–ABioGram–HIS), automated antibiogram validation, continuous AMR surveillance, and the impact of expert comments on clinical decision-making.
Official documents on healthcare development and antimicrobial resistance surveillance in the Russian Federation.
A review from CMAC (2025) compares WHO GLASS, CLSI M39, ESCMID, AMRcloud guidance and Russian MR 3.1.0346-24–highlighting key contradictions that matter for local antibiograms, data quality, and stewardship decisions.
How susceptibility testing accuracy, prescribing errors, and AMR diagnostics translate into measurable economic losses–and why even a 10% error rate can cost millions of rubles.